Clinical Trial Update: One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports one-year safety and tolerability results for azilsartan medoxomil in adults with essential hypertension. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Azilsartan medoxomil (azilsartan medoxomil)

Snippet

Sponsor: Takeda | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-04-19